Related Experiment Video
Updated: Jun 10, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes
Zhi-Xin Shan1, Qiu-Xiong Lin, Chun-Yu Deng
1Research Center of Guangdong General Hospital, Guangdong Provincial Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
Insights
MicroRNAs miR-1 and miR-206 increase in high glucose conditions, reducing Heat Shock Protein 60 (Hsp60) and promoting heart cell death in diabetes. This reveals a new mechanism in diabetic myocardial injury.
Area of Science:
- Cardiology
- Molecular Biology
- Diabetology
Background:
- Heat Shock Protein 60 (Hsp60) is crucial for defense against diabetic myocardial injury.
- The reasons for reduced Hsp60 levels in diabetic heart tissue are not fully understood.
Purpose of the Study:
- To investigate the role of microRNAs, specifically miR-1 and miR-206, in the regulation of Hsp60 expression under high glucose conditions.
- To elucidate the mechanism by which these microRNAs affect Hsp60 and contribute to cardiomyocyte apoptosis in diabetes.
Main Methods:
- Stimulation of cardiomyocytes with high glucose in both in vivo and in vitro models.
- Analysis of miR-1, miR-206, and Hsp60 expression levels.
- Investigation of the involvement of Serum Response Factor (SRF) and the MEK1/2 pathway.
- Assessment of cardiomyocyte apoptosis.
Main Results:
- High glucose significantly up-regulated miR-1 and miR-206 expression in cardiomyocytes.
- miR-1 and miR-206 were found to post-transcriptionally modulate Hsp60 expression.
- The SRF and MEK1/2 pathways were implicated in the regulation of miR-1 and miR-206.
- Increased miR-1 and miR-206 accelerated cardiomyocyte apoptosis by affecting Hsp60.
Conclusions:
- miR-1 and miR-206 play a key role in regulating Hsp60 expression in cardiomyocytes.
- These microRNAs contribute to high glucose-induced apoptosis in the diabetic heart.
- The findings identify a novel molecular pathway involved in diabetic myocardial injury.
Abstract:
Hsp60 is an important component of defense mechanisms against diabetic myocardial injury; however, the cause of Hsp60 reduction in the diabetic myocardium remains unknown. After stimulation of cardiomyocytes with high glucose in vivo and in vitro, significant up-regulation of miR-1/miR-206 and post-transcriptional modulation of Hsp 60 were observed. Serum response factor (SRF) and the MEK1/2 pathway were involved in miR-1 and miR-206 expression in cardiomyocytes. miR-1 and miR-206 regulated Hsp60 expression post-transcriptionally and accelerated cardiomyocyte apoptosis through Hsp60. These results revealed that miR-1 and miR-206 regulate Hsp60 expression, contributing to high glucose-mediated apoptosis in cardiomyocytes.
